Celecoxib-Tramadol Combo Tablet Approved for Acute Pain
Seglentis is a co-crystal formulation of celecoxib, an NSAID, and tramadol hydrochloride, an opioid agonist and inhibitor of norepinephrine and serotonin reuptake.
Home
Abaloparatide Looks Promising for Men With Osteoporosis
The phase 3 ATOM study evaluated the efficacy and safety of abaloparatide in 228 men with osteoporosis.
Zimhi Approved for Emergency Treatment of Opioid Overdose
Zimhi is intended for immediate administration as emergency therapy in settings where opioids may be present.
Peripheral Kinetic Perimetry Assists in Early Detection of Glaucoma
Combining peripheral kinetic visual field testing with central static perimetry improves early glaucomatous detection.
Extracorporeal Photopheresis in Pediatric Chronic Graft vs Host Disease
Researchers sought to determine whether extracorporeal photopheresis would be a safe treatment approach for children who have steroid-refractory cGVHD.
Vismodegib Demonstrates Efficacy in Basal Cell Carcinoma
Vismodegib treatment in local advanced and metastatic basal cell carcinoma is assessed.
Pandemic-Related Delays in Cancer Surgery May Not Affect Short-Term Outcomes
There was no increase in unresectable disease, new metastatic disease, or 30-day mortality associated with increasing delays.
Tavneos Approved for ANCA-Associated Vasculitis
The approval was based on data from the phase 3 ADVOCATE trial, which evaluated Tavneos in 330 adults with newly diagnosed or relapsed ANCA-associated vasculitis.
CaroSpir, a Liquid Form of Spironolactone, Now Available in Unit Dose Cups
The new packaging allows for ease of administration and convenience.
Lybalvi Now Available for Schizophrenia, Bipolar I Disorder
Lybalvi is an atypical antipsychotic comprised of samidorphan co-formulated with olanzapine in a single bilayer tablet.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in News
Loading... 
Loading...